SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-024877
Filing Date
2023-02-06
Accepted
2023-02-06 07:06:02
Documents
17
Period of Report
2023-02-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d406212d8k.htm   iXBRL 8-K 41059
2 EX-10.1 d406212dex101.htm EX-10.1 61100
3 EX-10.2 d406212dex102.htm EX-10.2 52530
4 EX-99.1 d406212dex991.htm EX-99.1 12867
8 GRAPHIC g406212g0204055501255.jpg GRAPHIC 2223
9 GRAPHIC g406212g0204070325828.jpg GRAPHIC 2372
  Complete submission text file 0001193125-23-024877.txt   350184

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vrdn-20230206.xsd EX-101.SCH 2888
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrdn-20230206_lab.xml EX-101.LAB 17993
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrdn-20230206_pre.xml EX-101.PRE 11286
11 EXTRACTED XBRL INSTANCE DOCUMENT d406212d8k_htm.xml XML 3396
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 23588354
SIC: 8071 Services-Medical Laboratories